|
|
|
Volumn 117 Suppl 5A, Issue , 2004, Pages
|
|
Therapeutic choices in reflux disease: defining the criteria for selecting a proton pump inhibitor.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE;
DRUG DERIVATIVE;
ENZYME INHIBITOR;
LANSOPRAZOLE;
OMEPRAZOLE;
PROTON PUMP;
ADULT;
AGED;
BIOAVAILABILITY;
COMPARATIVE STUDY;
DOSE RESPONSE;
DRUG ADMINISTRATION;
DRUG ANTAGONISM;
FEMALE;
GASTROESOPHAGEAL REFLUX;
HOSPITALIZATION;
HUMAN;
MALE;
MIDDLE AGED;
PATIENT SATISFACTION;
PH;
PROGNOSIS;
REVIEW;
RISK ASSESSMENT;
TREATMENT OUTCOME;
2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES;
ADULT;
AGED;
BIOLOGICAL AVAILABILITY;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
ENZYME INHIBITORS;
FEMALE;
GASTROESOPHAGEAL REFLUX;
HUMANS;
HYDROGEN-ION CONCENTRATION;
MALE;
MIDDLE AGED;
OMEPRAZOLE;
PATIENT SATISFACTION;
PROGNOSIS;
PROTON PUMPS;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
|
EID: 7044237246
PISSN: 00029343
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (14)
|
|
References (54)
|
